Access Bio Inc (950130) — Cash Flow Reinvestment Rate
Access Bio Inc (950130) has a Cash Flow Reinvestment Rate of 1548.52x as of March 2025, reinvesting ₩8.29 Billion (capex ₩635.11K plus investments ₩8.29 Billion) from operating cash flow of ₩5.35 Million. Explore 950130 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Access Bio Inc Cash Flow Reinvestment Rate (2012–2024)
Historical reinvestment intensity for Access Bio Inc across 8 annual periods. Also explore balance sheet size of Access Bio Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Access Bio Inc (2012–2024)
Year-by-year capital reinvestment analysis for Access Bio Inc. For live market cap and broader valuation context, see Access Bio Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1290.23x | ₩17.47 Billion | ₩13.54 Million | ₩1.40 Million | ▲ +895.2% |
| 2022 | 129.64x | ₩37.77 Billion | ₩291.33 Million | ₩14.90 Million | ▼ -48.9% |
| 2021 | 253.51x | ₩34.96 Billion | ₩137.90 Million | ₩28.76 Million | ▲ +85255.3% |
| 2020 | 0.30x | ₩10.91 Billion | ₩36.72 Billion | ₩10.38 Billion | ▼ -93.7% |
| 2016 | 4.74x | ₩10.03 Million | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩4.85 Billion | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩2.63 Billion | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.31 Billion | ₩1.85 Billion | ₩1.31 Billion | — |